# A Study to Evaluate the Efficacy and Safety of Flexible Dose of Quetiapine Fumarate (Seroquel) Switching From Other Drugs in the Treatment of Acute Manic Patients With Bipolar Disorder

> **NCT00837343** · PHASE4 · UNKNOWN · sponsor: **Guangzhou Mental Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** quetiapine fumarate tablet (Seroquel)

## Key facts

- **NCT ID:** NCT00837343
- **Lead sponsor:** Guangzhou Mental Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-12
- **Primary completion:** 2010-10
- **Final completion:** 2010-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2009-02-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00837343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00837343, "A Study to Evaluate the Efficacy and Safety of Flexible Dose of Quetiapine Fumarate (Seroquel) Switching From Other Drugs in the Treatment of Acute Manic Patients With Bipolar Disorder". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00837343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*